4//SEC Filing
Faulkes Martin Charles 4
Accession 0001078782-21-000679
CIK 0000093314other
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 5:00 PM ET
Size
8.0 KB
Accession
0001078782-21-000679
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
Faulkes Martin Charles
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2021-07-14−40,000→ 0 totalExercise: $4.00From: 2016-01-23Exp: 2021-07-23→ Common Stock (40,000 underlying) - Award
Stock Option (Right to Buy)
2021-07-14+40,000→ 40,000 totalExercise: $4.00From: 2016-01-23Exp: 2025-07-23→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on July 23, 2015, vested in full and were exercisable at 6 months from the date of grant, and as amended were exercisable for five years and six months from the date first exercisable. The "replacement" options are fully-vested and expire on July 23, 2025 (ten years from the date of grant).
Documents
Issuer
VOLITIONRX LTD
CIK 0000093314
Entity typeother
Related Parties
1- filerCIK 0001577872
Filing Metadata
- Form type
- 4
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 5:00 PM ET
- Size
- 8.0 KB